Radcliffe Cardiology is proud to announce a new one-day event, Advancements in Obesity Management (AOM). Explore the intricate links between obesity and cardiovascular disease, gaining key insights in evolving diagnostic and treatment strategies.
Join us for this live one-day event on Wednesday 12 June 2024 to deepen your understanding of the multifaceted treatment of obesity and cardiovascular diseases.
This event, led by Course Directors Dr Harold Bays (Louisville Metabolic and Atherosclerosis Research Centre, US) and Prof Naveed Sattar (University of Glasgow, UK) brings together a distinguished group of global faculty members who are renowned experts in the field of obesity and cardiovascular disease.
Register now to be at the forefront of advancements in practical obesity therapy. We look forward to welcoming you to this first-time event.
*Advancements in Obesity Management’s programme has been accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 4 CME credits, equating to 4 hours of effective education time. Physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™
Advancements in Obesity Management (AOM) is endorsed by the ISCP
(Please note this programme is subject to change)
Day Welcome
Event Welcome
Welcome and Introduction
Plenary Session
Session 1: Obesity as a Disease, Diagnosis, and Cardiovascular Disease Risk
-
Introduction to a patient living with obesity
-
Defining the disease of obesity including accurate diagnosis and broad implications of the disease
-
Obesity and mechanisms leading to cardiovascular disease
-
An overview of cardiovascular risk reduction therapies current and emerging
Plenary Session
Session 2: Rapid Fire Sessions - Challenges of Treating Specific CV Disease in Patients With Obesity
-
A review of key co morbidities found in patients living with obesity including diabetes, hypertension, dyslipidemia, thrombosis, heart failure and atrial fibrillation
-
The impact, challenges, strategies and emerging data will be discussed
Break
Break
Plenary Session
Session 3: Healthful Nutrition, Physical Activity, Behaviour Modification and MDT
How to speak with a patient living with obesity
Healthcare biases and the impact on patients
Latest on healthful nutrition, behaviour modification and additional therapy approaches
How to practically implement and utilise tools for non-drug therapies
How to utilise and work with a multidisciplinary team
Plenary Session
Session 4: Medical and Procedural Options and the Referral Pathways
Utilisation of medical therapy for patients living with obesity – practical considerations
Review of clinical outcome evidence and when to refer patients for surgery
Current gaps and future therapies
Practical management with the multidisciplinary team
Day Summary
Event Close
Closing Remarks
Harold Bays
Course Director
Louisville Metabolic and Atherosclerosis Research Center, Louisville, US
more info
Naveed Sattar
Course Director
University of Glasgow, Glasgow, UK
more info
Faculty
Lydia Alexander
Enara Health, California, US
Vanita Aroda
Brigham and Women’s Hospital, Boston, US
Harold Bays
Louisville Metabolic and Atherosclerosis Research Center, Louisville, US
Ozden Gokdemir
Izmir University of Economics, Faculty of Medicine, Izmir, TR
Mikhail Kosiborod
Saint Luke’s Mid America Heart Institute, Kansas City, US
Linda Mellbin
Karolinska University Hospital, Stockholm, SE
Erin Michos
Johns Hopkins School of Medicine, Baltimore, US
Alexander Miras
Ulster University, Belfast, UK
Neha Pagidipati
Duke University School of Medicine, North Carolina, US
Francesco Rubino
King's College London, London, UK
Naveed Sattar
University of Glasgow, Glasgow, UK
Liesbeth van Rossum
Erasmus University, Rotterdam, NL
- To understand the complex and multifactorial relationship between obesity and CV disease, including the biological, behavioural, and environmental factors that contribute to this relationship
- To understand the impacts of obesity across the CV disease spectrum
- Apply current treatment methodologies to reduce the impact of obesity on CV disease utilising the multidisciplinary team
- Cardiologists
- Primary Care Physicians
- Endocrinologists
- Diabetologists
- Obesity Specialists
If you’re interested in becoming an educational partner at AOM, please contact sales@radcliffe-group.com
Official Journal
European Cardiology Review (ECR) is an international, English-language, peer-reviewed journal that publishes articles continuously on ECRjournal.com. It aims to assist time-pressured physicians to stay abreast of key advances and opinions in the area of cardiovascular disease.
The journal comprises balanced and comprehensive review articles written by leading authorities. The journal provides updates on a range of salient issues to support physicians in developing their knowledge and effectiveness in day-to-day clinical practice.
The journal endeavours to support the continuous medical education of specialist and general cardiologists and disseminate knowledge of the field to the wider cardiovascular community.
About Radcliffe Cardiology
We are Radcliffe, a knowledge network for the cardiovascular community
We’re here to bring cardiovascular knowledge, insight and innovation to life for clinicians around the world, using our communications and creative expertise, our platforms and connections across the community to help transform theory into practice faster and more effectively.
We bring medical knowledge to life
From great science writing and smart journal editing, the curation of evidence based and peer-reviewed content, to engaging new formats that cut through the noise, we believe that communication is at the heart of great healthcare.
Our work is underpinned by 3 core principles:
- We build on the best science
- We work hands-on with our community
- We bring fresh thinking
Our promise is that we’ll equip you with the latest knowledge and skills you need, to do the best for your patients.
For more information on Radcliffe Cardiology, please visit www.radcliffecardiology.com